Latest Coronavirus vaccine update: This year Christmas gift could be COVID-19 vaccine

By: |
New Delhi | November 19, 2020 9:48 AM

Coronavirus Covid-19 vaccine update: Moderna vaccine is likely to be authorized seven to 10 days after Pfizer receives its EUA,

Coronavirus vaccine, Coronavirus vaccine update, Coronavirus vaccine USA, Coronavirus vaccine OXFORD, Coronavirus vaccine tracker, Coronavirus vaccine latest news, Coronavirus vaccine status, covid 19 vaccine, covid 19 vaccine update India, covid 19 vaccine latest update, covid 19 vaccine news, covid 19 vaccine update news, covid 19 vaccine Oxford, Pfizer vaccine, Pfizer covid vaccine, Pfizer corona vaccine, moderna vaccine, moderna India, moderna vaccine update,Coronavirus Covid-19 vaccine update: Oxford-AstraZeneca said that the late-stage date of their Covid-19 vaccine candidate AZD1222-ChAdOx1nCoV-19 would likely to be announced in November or December. (Reuters image)

Coronavirus Covid-19 vaccine update: It could be merry Christmas and a happy new year as Pfizer and BioNTech are preparing to start deliveries of their Covid-19 vaccine candidate BNT162b2 before December 25. BioNTech Chief Executive Ugur Sahin was quoted as saying by Reuters that emergency-use approval from the US Food and Drug Administration and the conditional approval from European Union could be obtained by the middle of December and the second half of December respectively and distribution can commence before Christmas.

BioNTech Chief Executive’s statement came after Pfizer disclosed final trial results showing its vaccine candidate had a 95 per cent success rate and no serious side effects. Pfizer has already launched a pilot delivery program for its BNT162b2 Coronavirus vaccine in four states of the US – Texas, New Mexico, Rhode Island, and Tennessee.

BioNTech claimed that the application for the emergency use authorization (EUA) from the US FDA would be submitted on Friday (local time). However, an advisory panel of the US FDA is likely to meet on December 8 to December 10 to deliberate on the Pfizer vaccine, as per a Reuters report.

Pfizer has revealed that it was expecting to produce around 50 million (5 crore) vaccine doses in 2020. The drugmaker said this will be enough to protect 25 million people (2.5 crore), and it can produce up to 1.3 billion (130 crore) doses in 2021. Pfizer has already made an offer to Brazil for providing millions of doses in the first half of 2021. Pfizer has entered agreements with the European Union, Germany, and Japan, and distribution in these countries could begin in 2021, the Reuters report says.

Moderna, Oxford Covid-19 vaccine: This week Moderna has also revealed a preliminary report that its mRNA-1273 Covid-19 vaccine candidate has shown 94.5 per cent efficacy rate. Moderna vaccine is likely to be authorized seven to 10 days after Pfizer receives its EUA, US officials said adding that states would be ready to begin distribution within 24 hours.

Oxford-AstraZeneca said that the late-stage date of their Covid-19 vaccine candidate AZD1222-ChAdOx1nCoV-19 would likely to be announced in November or December. Johnson & Johnson said it was on track to deliver data in 2020.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1DCGI finds no link between COVID vaccine shot and ‘adverse’ reaction in Chennai volunteer during trial: Sources
2Russia’s Vladimir Putin orders mass vaccination against COVID-19 next week
3COVID-19 vaccine: Covaxin Phase-3 trials begins in Karnataka